Pharmacological and functional biochemical properties of D-Ala 2-D-Nle5-enkephalin-Arg-Phe

Fanni Tóth, G. Horváth, Margit Szikszay, J. Farkas, Géza Tóth, A. Borsodi, S. Benyhe

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Tyr-D-Ala-Gly-Phe-D-Nle-Arg-Phe (DADN) a synthetic analogue of the endogenous Met-enkephalin-Arg-Phe (Tyr-Gly-Gly-Phe-Met-Arg-Phe; MERF), was investigated in radioligand binding assays, [35S]GTPγS stimulation experiments as well as in in vivo algesiometric tests. Binding properties of [3H]DADN were measured in crude membrane fractions of rat spinal cord tissues and in homogenates of Chinese hamster ovary (CHO) cells selectively expressing δ-, κ-or μ-opioid receptors. The highest affinity for [3H]DADN binding was observed in membranes from CHO cells transfected with μ-opioid receptors confirming the μ-selectivity of the peptide. Unlabeled DADN was also investigated in functional biochemical experiments by measuring opioid receptor-mediated G-protein activation in rat brain membrane fractions. The peptide stimulated the activity of the regulatory G-proteins in a concentration dependent manner, and the stimulation was efficiently inhibited in the presence of μ-receptor specific antagonist ligands further supporting the selectivity profile of DADN. Intrathecally administered DADN produced a dose-related, naloxone-reversible antinociception in rat hot water tail-flick tests. Among the selective opioid antagonists tested, the δ-selective naltrindole (NTI) and the κ-specific norbinaltorphimine (norBNI) showed only slight blocking effects compared with naloxone. The results obtained in the in vitro agonist-stimulated [ 35S]GTPγS binding assays are in good agreement with the opioid agonist effect seen in the in vivo pain test.

Original languageEnglish
Pages (from-to)139-146
Number of pages8
JournalRegulatory Peptides
Volume122
Issue number2
DOIs
Publication statusPublished - Oct 15 2004

Fingerprint

Enkephalins
Opioid Receptors
Rats
Methionine Enkephalin
naltrindole
Arg(6)-Phe(7)-enkephalin-met
Pharmacology
Naloxone
Cricetulus
Membranes
GTP-Binding Proteins
Ovary
Assays
Radioligand Assay
Peptides
Narcotic Antagonists
Opioid Analgesics
Tail
Brain
Spinal Cord

Keywords

  • CHO cells
  • Enkephalins
  • G-protein stimulation
  • Opioid receptor
  • Radioligand binding
  • Tail-withdrawal

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

Pharmacological and functional biochemical properties of D-Ala 2-D-Nle5-enkephalin-Arg-Phe. / Tóth, Fanni; Horváth, G.; Szikszay, Margit; Farkas, J.; Tóth, Géza; Borsodi, A.; Benyhe, S.

In: Regulatory Peptides, Vol. 122, No. 2, 15.10.2004, p. 139-146.

Research output: Contribution to journalArticle

@article{cd9fb3c116844e1db884e485abcfdbd4,
title = "Pharmacological and functional biochemical properties of D-Ala 2-D-Nle5-enkephalin-Arg-Phe",
abstract = "Tyr-D-Ala-Gly-Phe-D-Nle-Arg-Phe (DADN) a synthetic analogue of the endogenous Met-enkephalin-Arg-Phe (Tyr-Gly-Gly-Phe-Met-Arg-Phe; MERF), was investigated in radioligand binding assays, [35S]GTPγS stimulation experiments as well as in in vivo algesiometric tests. Binding properties of [3H]DADN were measured in crude membrane fractions of rat spinal cord tissues and in homogenates of Chinese hamster ovary (CHO) cells selectively expressing δ-, κ-or μ-opioid receptors. The highest affinity for [3H]DADN binding was observed in membranes from CHO cells transfected with μ-opioid receptors confirming the μ-selectivity of the peptide. Unlabeled DADN was also investigated in functional biochemical experiments by measuring opioid receptor-mediated G-protein activation in rat brain membrane fractions. The peptide stimulated the activity of the regulatory G-proteins in a concentration dependent manner, and the stimulation was efficiently inhibited in the presence of μ-receptor specific antagonist ligands further supporting the selectivity profile of DADN. Intrathecally administered DADN produced a dose-related, naloxone-reversible antinociception in rat hot water tail-flick tests. Among the selective opioid antagonists tested, the δ-selective naltrindole (NTI) and the κ-specific norbinaltorphimine (norBNI) showed only slight blocking effects compared with naloxone. The results obtained in the in vitro agonist-stimulated [ 35S]GTPγS binding assays are in good agreement with the opioid agonist effect seen in the in vivo pain test.",
keywords = "CHO cells, Enkephalins, G-protein stimulation, Opioid receptor, Radioligand binding, Tail-withdrawal",
author = "Fanni T{\'o}th and G. Horv{\'a}th and Margit Szikszay and J. Farkas and G{\'e}za T{\'o}th and A. Borsodi and S. Benyhe",
year = "2004",
month = "10",
day = "15",
doi = "10.1016/j.regpep.2004.06.017",
language = "English",
volume = "122",
pages = "139--146",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Pharmacological and functional biochemical properties of D-Ala 2-D-Nle5-enkephalin-Arg-Phe

AU - Tóth, Fanni

AU - Horváth, G.

AU - Szikszay, Margit

AU - Farkas, J.

AU - Tóth, Géza

AU - Borsodi, A.

AU - Benyhe, S.

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Tyr-D-Ala-Gly-Phe-D-Nle-Arg-Phe (DADN) a synthetic analogue of the endogenous Met-enkephalin-Arg-Phe (Tyr-Gly-Gly-Phe-Met-Arg-Phe; MERF), was investigated in radioligand binding assays, [35S]GTPγS stimulation experiments as well as in in vivo algesiometric tests. Binding properties of [3H]DADN were measured in crude membrane fractions of rat spinal cord tissues and in homogenates of Chinese hamster ovary (CHO) cells selectively expressing δ-, κ-or μ-opioid receptors. The highest affinity for [3H]DADN binding was observed in membranes from CHO cells transfected with μ-opioid receptors confirming the μ-selectivity of the peptide. Unlabeled DADN was also investigated in functional biochemical experiments by measuring opioid receptor-mediated G-protein activation in rat brain membrane fractions. The peptide stimulated the activity of the regulatory G-proteins in a concentration dependent manner, and the stimulation was efficiently inhibited in the presence of μ-receptor specific antagonist ligands further supporting the selectivity profile of DADN. Intrathecally administered DADN produced a dose-related, naloxone-reversible antinociception in rat hot water tail-flick tests. Among the selective opioid antagonists tested, the δ-selective naltrindole (NTI) and the κ-specific norbinaltorphimine (norBNI) showed only slight blocking effects compared with naloxone. The results obtained in the in vitro agonist-stimulated [ 35S]GTPγS binding assays are in good agreement with the opioid agonist effect seen in the in vivo pain test.

AB - Tyr-D-Ala-Gly-Phe-D-Nle-Arg-Phe (DADN) a synthetic analogue of the endogenous Met-enkephalin-Arg-Phe (Tyr-Gly-Gly-Phe-Met-Arg-Phe; MERF), was investigated in radioligand binding assays, [35S]GTPγS stimulation experiments as well as in in vivo algesiometric tests. Binding properties of [3H]DADN were measured in crude membrane fractions of rat spinal cord tissues and in homogenates of Chinese hamster ovary (CHO) cells selectively expressing δ-, κ-or μ-opioid receptors. The highest affinity for [3H]DADN binding was observed in membranes from CHO cells transfected with μ-opioid receptors confirming the μ-selectivity of the peptide. Unlabeled DADN was also investigated in functional biochemical experiments by measuring opioid receptor-mediated G-protein activation in rat brain membrane fractions. The peptide stimulated the activity of the regulatory G-proteins in a concentration dependent manner, and the stimulation was efficiently inhibited in the presence of μ-receptor specific antagonist ligands further supporting the selectivity profile of DADN. Intrathecally administered DADN produced a dose-related, naloxone-reversible antinociception in rat hot water tail-flick tests. Among the selective opioid antagonists tested, the δ-selective naltrindole (NTI) and the κ-specific norbinaltorphimine (norBNI) showed only slight blocking effects compared with naloxone. The results obtained in the in vitro agonist-stimulated [ 35S]GTPγS binding assays are in good agreement with the opioid agonist effect seen in the in vivo pain test.

KW - CHO cells

KW - Enkephalins

KW - G-protein stimulation

KW - Opioid receptor

KW - Radioligand binding

KW - Tail-withdrawal

UR - http://www.scopus.com/inward/record.url?scp=4544278750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544278750&partnerID=8YFLogxK

U2 - 10.1016/j.regpep.2004.06.017

DO - 10.1016/j.regpep.2004.06.017

M3 - Article

C2 - 15380931

AN - SCOPUS:4544278750

VL - 122

SP - 139

EP - 146

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 2

ER -